Request for Covid-19 Impact Assessment of this Report
Market Dynamics
As indicated by the World Health Organization, the number of surgeries performed across the globe has increased and this trend is projected to continue due to increasing prevalence of chronic diseases, healthcare expenditure, and technological advancements. Inhalation anesthetics offer shorter induction and recovery time with better efficiency. Also, Inhalation anesthetics in conjugation with intravenous and other anesthetic agents offer better anesthetic effect during surgical procedures. These factors are anticipated to drive the inhalation anesthetics market during the forecasted time frame. Further, growing investment in healthcare infrastructure, development in emerging economies and increasing adoption of universal health coverage will spur the business growth.
Market Segmentation
The global inhalation anesthetics market has been segmented based on product, end-user, and geography. On basis of product, the market has been segmented into volatile liquid agents and gaseous agents. The volatile liquid agents segment is sub-segmented into sevoflurane, desoflurane, isoflurane, and others. The gaseous agents market is also divided into nitrous oxide, xenon and others. A significant share of the global market is held by the gaseous agents owing to usage as a conjugate catalyst in other anesthetic agents such as injectable and oral. Based on user type the global market has been segmented into hospitals, ambulatory surgical centers, and others.
Regional/Geographic Analysis
The global Inhalation Anesthetics Market has been segmented in terms of region into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. The well-established healthcare infrastructure and advancement in technologies have contributed North America to hold a significant share of the global market. Furthermore, the presence of associations that facilitate in maintaining the standards of anesthesiology will propel the industry growth in the country. The improvement in healthcare infrastructure and increase in the number of surgeries performed in Asian countries such as China and India will contribute to expanding the inhalation anesthetics market in Asia Pacific during the forecast period.
Key Players
Some of the major players in the global Inhalation Anesthetics Market include Hikma Pharmaceuticals, Baxter International, Inc., AbbVie, Inc., Halocarbon Products Corporation, Piramal Healthcare, Mylan NV, Maruishi Pharmaceuticals Co. Ltd., Jiangsu Hengrui Medicine Co., Ltd., Neon Laboratories Ltd., Lunan Pharmaceuticals, andTroikaa Pharmaceuticals Ltd.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...